Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Strieter

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Cell Metabolism|February 4, 2009
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signalingFabienne T Schulthess, Federico Paroni, Nadine S Sauter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer modelSven Hillinger, Seok-Chul Yang, Li Zhu, et al.
Plos One|March 24, 2012
The role of fibrocytes in sickle cell lung diseaseJoshua J Field, Marie D Burdick, Michael R DeBaun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancerAsa Andersson, Seok-Chul Yang, Min Huang, et al.
Infection and Immunity|January 31, 2009
Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilliMatthew A Crawford, Yinghua Zhu, Candace S Green, et al.
Transplantation|March 13, 2002
Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipientsJohn A Belperio, Bruno DiGiovine, Michael P Keane, et al.
Cancer Research|October 19, 2007
Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growthTomoatsu Kaneko, Zhaocheng Zhang, Maria G Mantellini, et al.
Pediatric Pulmonology|July 2, 2015
Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemiaMatthew S Karafin, Shibani Dogra, Mark Rodeghier, et al.
The Journal of Clinical Investigation|August 3, 2004
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosisRoderick J Phillips, Marie D Burdick, Kurt Hong, et al.
Cancer Letters|February 7, 2006
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesisMoritz N Wente, Michael P Keane, Marie D Burdick, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Cell Metabolism|February 4, 2009
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signalingFabienne T Schulthess, Federico Paroni, Nadine S Sauter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer modelSven Hillinger, Seok-Chul Yang, Li Zhu, et al.
Plos One|March 24, 2012
The role of fibrocytes in sickle cell lung diseaseJoshua J Field, Marie D Burdick, Michael R DeBaun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancerAsa Andersson, Seok-Chul Yang, Min Huang, et al.
Infection and Immunity|January 31, 2009
Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilliMatthew A Crawford, Yinghua Zhu, Candace S Green, et al.
Transplantation|March 13, 2002
Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipientsJohn A Belperio, Bruno DiGiovine, Michael P Keane, et al.
Cancer Research|October 19, 2007
Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growthTomoatsu Kaneko, Zhaocheng Zhang, Maria G Mantellini, et al.
Pediatric Pulmonology|July 2, 2015
Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemiaMatthew S Karafin, Shibani Dogra, Mark Rodeghier, et al.
The Journal of Clinical Investigation|August 3, 2004
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosisRoderick J Phillips, Marie D Burdick, Kurt Hong, et al.
Cancer Letters|February 7, 2006
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesisMoritz N Wente, Michael P Keane, Marie D Burdick, et al.
Pageof 18